← Back to TGTX

TG THERAPEUTICS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 05/08/2026Sep 2025Filed 05/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 05/08/2026Sep 2024Filed 05/11/2025Jun 2024Filed 05/11/2025Mar 2024Filed 05/11/2025
$240$205$162$141$121$84$73$63
$7.8$20$391$28$5.1$3.9$6.9−$11
$0.05$0.12$2.43$0.17$0.03$0.02$0.04−$0.07
157160161163163161159146

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.